UCSF at ASCO 2025
Each year UCSF Helen Diller Family Comprehensive Cancer Center members, physicians, faculty members, and advocates participate in the Annual Meeting of the American Society of Clinical Oncology (ASCO).
The international conference will feature many hundreds of sessions complementing this year’s theme, “Driving Knowledge to Action: Building a Better Future,” with more than 5,000 abstracts to be presented or published as part of ASCO’s 2025 meeting.
UCSF’s Eric J. Small, MD, FASCO, the current president-elect of ASCO, will begin his term as president for 2025-2026 immediately following ASCO’s annual business meeting on June 2. Small has chosen “The Science and Practice of Translation: Improving Cancer Outcomes Worldwide” as the presidential theme for his tenure.
In the News
- Predictive Biomarkers, Tailored Therapy Among Conference Presentations | UCSF’s Eric J. Small, MD, takes reins as ASCO president immediately following ASCO 2025 meeting | UCSF.edu 5/30/25
- T-DXd Rechallenge After Grade 1 ILD Appears Safe, Study Finds | Doc Wire News 5/30/25
- ASCO 2025: Expert Insights on Endocrine, Cardiac, Ocular, and Dermatologic Toxicities in Breast Cancer Care | Pharmacy Times 6/2/25
- ASCO 2025: External Validation of a Pathology-Based Multimodal Artificial Intelligence Biomarker for Predicting Prostate Cancer Outcomes after Prostatectomy | UroToday 6/3/25
- ASCO 2025: Prognostic Utility of ctDNA Before and After Trimodality Therapy (TMT) for Muscle Invasive Bladder Cancer | UroToday 6/4/25
Featured videos of presenters and attendees
- Samuel Washington, MD | Osteoporosis and Metastatic Prostate Cancer
- Scott Swartz, MD, MS | Global Cancer Delivery
- Jo Chien, MD | ctDNA for Breast Cancer
- Silver Alkhafaji | Updates from I-SPY2
- Lorraine Jiang | RECAST Trials for DCIS
- Rita Mukhtar, MD | ctDNA for Surgical Planning
2025 ASCO President: Eric Small, MD, FASCO
Dr. Eric J. Small Elected ASCO President for 2025-2026 Term | ASCO Connection
Photos by © ASCO/Scott Morgan 2025
UCSF colleagues were on hand to welcome Dr. Small in his new role, at a reception during the annual meeting.
-
Dr. Eric J. Small Elected ASCO President for 2025-2026 Term | ASCO Connection
-
Ana Velázquez Mañana, MD, MSc was awarded the 2025 Health Equity Award during Healio's Disruptive Innovators Awards ceremony.
Honors and Awards
CONQUER CANCER AWARDEES
Among the many HDFCCC-affiliated award winners were:
2025 ASCO Annual Meeting Merit Award Recipients
- Silver Alkhafaji, BS
- Vardhaan Ambati, MS
- Johanna Balas, MD
- Darwin Kwok, PhD, BS, MS
Highlights on Social Media
Deeply honored to step into the role of 2025-26 @ASCO President. My focus will be guided by the theme, "The Science and Practice of Translation: Improving Cancer Outcomes Worldwide." Looking forward to a productive & collaborative year ahead with our incredible ASCO community! pic.twitter.com/57ovKqRFcA
— Eric J. Small, MD, FASCO (@ASCOPres) June 2, 2025
Congrats to Dr.Jeremiah Wala, the first @ASCO Dr.Felix Feng Endowed Young Investigator Awardee. Thanks to his friends and colleagues and @ConquerCancerFd for ensuring his legacy of creative science and a commitment to collaboration. @ASCOPres @ericlfeng @nlinmd pic.twitter.com/UqXxrVTZ3m
— Mary Feng (@MaryFengMD) June 4, 2025
Congratulations 👏🏻👏🏻👏🏻to 🌟Dr Ana Velazquez-Manana🌟 for receiving the Healio Disruptive Innovators Health Equity Award at #ASCO25! 🎉🎉 @UCSFCancer 🔥 pic.twitter.com/SGHf4krJp2
— Katherine Van Loon, MD, MPH (@KVanLoonMD) June 1, 2025
So grateful to be able to meet with @KVanLoonMD again during the @JCO_ASCO mentoring session! Appreciate all of the #globaloncology career advice & your leadership with @JCOGO_ASCO & cancer care around the world! We live in uncertain times but the work still must be done! #ASCO25 https://t.co/ieI4iIspRI pic.twitter.com/QMGm2G9RR2
— James Wu | 吴简凡 MD (@JamesFanWu) June 3, 2025
Post your #ASCO25HappyDance to energize each other for the coming year as we continue to work toward conquering cancer! #ASCO25 @ConquerCancerFd @JoshLangMD @nlinmd @rachnatshroff @UCSFCancer @mishabeltran https://t.co/a77hRrSW5z
— Mary Feng (@MaryFengMD) June 2, 2025
Proud to share our work analyzing NCCN Harmonized Guidelines for Sub-Saharan Africa (ASCO abstract 1510), presented by UCSF IM R2 Scott Swartz pic.twitter.com/IMApIgAZij
— Geoffrey Buckle (@geoffreybuckle) June 3, 2025
Congratulations to @UCSFHospitals neuro-oncologist Susan Chang, MD, on being named a Fellow of the @ASCO for her dedication to volunteer service efforts within oncology that have benefitted the patients and the field! 🎉 #ASCO25 @UCSFCancer pic.twitter.com/12m9JGiqm1
— UCSF Neurosurgery (@NeurosurgUCSF) June 3, 2025
Kudos to Jeremiah Wala, MD, PhD @danafarber.bsky.social on receiving the first Dr. Felix Feng Endowed Young Investigator Award at #ASCO25. Thank you to @ascocancer.bsky.social and all who made this tribute to our beloved Dr. Feng a reality.
— UCSF Helen Diller Family Comprehensive Cancer Center (@ucsfcancer.bsky.social) June 1, 2025 at 6:55 PM
[image or embed]
#ASCO25 Arce-Ruiz: identified ~30K w CH vs 440K wo CH in Biobank DB. Age-related macular degeneration (AMD) appears to be modestly assoc w CH (HR 1.15) but no specific gene mutation indicted as culprit. CH not assoc w vision loss in those with AMD.
— Aaron Logan, MD, PhD, MPhil (@hemedoc.bsky.social) May 30, 2025 at 12:25 PM
[image or embed]
Ok #OncSky, what social media platforms do you plan to use most for #ASCO25 content? (And yes I know I’m asking on BlueSky so…). Can’t do a poll here but please vote in replies! #MedSky Twitter BlueSky LinkedIn Instagram or other
— Tatiana Prowell, MD (@tmprowell.bsky.social) May 29, 2025 at 4:53 AM
Fantastic and clinically relevant session on #iRAE identification & management in both academic and community settings, highlighting strategies for implementation of #immunotherapy toxicity management clinics, collaboration & co-management with other specialties, and the role of… pic.twitter.com/K8sSIWELOe
— Ana I. Velázquez Mañana, MD, MSc, FASCO (@AnaVManana) May 30, 2025
Science matters; Translation; Impact. As the government steps back in global care, @ASCO must step up to fill the void. @UCSFCancer GU oncologist and @ANCO_News member Eric Small inaugurated as ASCO president. #ASCO25 pic.twitter.com/BQBYz7qzXl
— Steve Lee (@steveleeyc) June 2, 2025
Psst ... want to see how we're brewing up #ASCO25? We're busy behind the scenes making sure everything's just right! Can't WAIT to officially open the doors, welcome everyone, and get this Annual Meeting party started! See you there!
— American Society of Clinical Oncology (@ascocancer.bsky.social) May 29, 2025 at 12:43 PM
[image or embed]
Congrats @KelseyNatsuhara on this excellent multi-center retrospective study of T-DXd rechallenge after grade 1/2 ILD 🫁. @hoperugo @UCSFCancer
— Laura Huppert, MD (@laura_huppert) May 30, 2025
🔹 Rechallenge after grade 1 ILD is safe w/ low rates of ILD recurrence & no G5 events
🔹 Pts remained on T-DXd a median 215 days (!)… https://t.co/ZOwDknVo3m